Navigation Links
Elevated Blood Sugar Levels A Risk Factor Of Heart Disease

High levels of glycosylated hemoglobin, or HA1c, may be an independent risk factor for cardiovascular events, such as heart disease // and stroke, according to the new research. Two new studies show a strong link between blood sugar control and the development of heart disease and stroke.

In a six-year study of more than 10,000 people, investigators found a 21-percent increase in cardiovascular events for every percentage point increase in HA1c above 5 percent. The level of glycosylated hemoglobin was associated with these events even in people who did not have diabetes and who had HA1c levels within normal range.

An analysis of previous studies shows the risk for cardiovascular disease increased with increasing levels of glycosylated hemoglobin. However, the study did not prove better control of blood sugar would prevent cardiovascular disease.

Researchers suggest that further investigations be done to study whether improvements in glycemic control may improve health outcomes in people who do not have diabetes.
'"/>




Page: 1

Related medicine news :

1. Elevated Ozone Levels Hurt Sperm Count
2. Elevated homocysteine levels linked to congestive heart failure risk
3. Elevated LDL levels in Childhood could be Predictors of Heart Disease
4. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
5. Diabetic Type II Women Have Elevated Bone Density Mass
6. Males Lifespan Shortened By Elevated Levels Of Testosterone
7. Adults Needs to be Educated About the Dangers of Elevated TVs
8. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
9. New Therapy to Treat Patients With Severely Elevated Cholesterol Levels
10. Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals
11. Higher Trans Fat Levels in Blood Associated With Elevated Risk of Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... 25, 2017 , ... CareSet Labs released the Root NPI Graph today at ... new, greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. ... subsequently called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as ...
(Date:6/24/2017)... ... June 24, 2017 , ... The Pennsylvania Athletic Trainers’ ... Bayfront and Erie Convention Center on June 8-10. The weekend consisted of ... bowl, award and scholarship presentations, and professional networking. , On Friday June ...
(Date:6/23/2017)... ... 2017 , ... The Rhode Island Quality Institute (RIQI) and ... Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care and ... Dashboards provide near real-time data about patients admitted to and/or discharged from acute ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids ... risk of visual loss in these patients. , But how often do ophthalmologists and ... cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... , ... June 23, 2017 , ... Everybody has their ... while others prefer to read it, and some people don't like it at all. ... Here's what they found: , Erotic literature can give readers a taste of their ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
Breaking Medicine Technology: